Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Palliative care is recommended for patients with cancer with a life expectancy of <12 months. Machine learning (ML) techniques can help in predicting survival outcomes among patients with cancer and ...

Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond ...

Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...

Cancer, a leading cause of death globally, accounts for over 10 million fatalities each year. While traditional cancer treatments, primarily focusing on the ...

Fred Hutchinson Cancer Center-led investigators found that higher patient-reported fatigue before cancer treatment aligned with higher odds of severe, life-threatening, and fatal treatment-related ...